Menten AI

Visit website

overall

15,655

out of 61,834

+2041

traffic

16,131

out of 61,834

+1266

investment

4,182

out of 61,834

review

Not Available

These rankings are based on data from February 2026

Company

Menten AI

Years in business

Number of employees

2-10 employees

Country

United States

Menten AI's platform utilizes advanced generative AI and physics-based modeling to design novel peptide drugs, overcoming traditional design limitations and optimizing in silico drug properties efficiently.

API Availability

Pricing

paid

Use

clinical research

drug discovery & development

Position of Menten AI on sub rankings

February 2026

Drug discovery & development - Overall

27 out of 62

United States - Overall

6,388 out of 16,935

Drug discovery & development - Overall

27 out of 62

United States - Overall

6,388 out of 16,935

Industries

health & sports

Company

Menten AI

Years in business

Number of employees

2-10 employees

Country

United States

Help us improve this profile

Insights

If you want a real AI ecosystem, builders need a place to build

Philip Gast on AI products, startup culture, and why too much of the Dutch ecosystem still feels too stiff and too commercial.

“Your rankings are wrong.” Perfect! That means they work.

If RankmyAI rankings feel wrong, it is often because they measure something different. Instead of popularity, we rank AI tools based on combined traction across traffic, investment, and user reviews. This article explains the logic behind that approach and why it leads to less intuitive, but more informative outcomes.